Medicine
Clomid 50 mg tablet
Clomid 50 mg tablet is a prescription medicine containing Clomiphene for oral use, marketed by Cosette Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store tablets at controlled room temperature 15° to 30°C (59° to 86°F)…
Key facts
- Active ingredient (INN)
- Clomiphene
- Brand
- Clomid
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 blister pack, 3 blister pack
- Marketing authorisation holder
- Cosette Pharmaceuticals
- Manufacturers
- Cosette PharmaceuticalsA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Store tablets at controlled room temperature 15° to 30°C (59° to 86°F). Protect from heat, light, and excessive humidity, and store in closed containers.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G03GB02 Clomiphene
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 September 2022
- Identifiers
- RxCUI 1093060, 1093073DailyMed set ID f15e9918-6001-4150-bd54-1364a6febcb8, 2ca373c1-4dba-4126-8616-5c533d606fe5NDC 50090-6500, 0713-0885Application ANDA075528
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 carton / 10 tablet in 1 blister pack | 0713-0885-09 | Cosette Pharmaceuticals | 12 September 2022 |
| 3 blister pack in 1 carton / 10 tablet in 1 blister pack | 0713-0885-30 | Cosette Pharmaceuticals | 9 September 2022 |
| 3 blister pack in 1 carton / 10 tablet in 1 blister pack | 50090-6500-0 | A-S Medication Solutions | 24 May 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 1 February 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Clomiphene 50 mg tablet.
Clinical summary
Clomiphene is an estrogen agonist/antagonist indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. It is available as tablets for oral use. MedsAcross supplies Clomiphene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClomipheneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Clomiphene Citrate prescribing information (Accord Healthcare) · U.S. National Library of Medicine, DailyMed
Need Clomid 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.